Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 13, 2024
Abstract
Protection
from
COVID-19
vaccination
is
suboptimal
in
many
immunocompromised
individuals.
In
March
2024,
the
Food
and
Drug
Administration
issued
an
Emergency
Use
Authorization
for
pemivibart
(Permagard/VYD222),
engineered
human
monoclonal
antibody,
pre-exposure
prophylaxis
this
vulnerable
population.
However,
SARS-CoV-2
has
since
evolved
extensively,
resulting
multiple
Omicron
JN.1
sublineages.
We
therefore
evaluated
vitro
neutralizing
activity
of
against
prevalent
forms
JN.1,
including
KP.2,
KP.3,
KP.2.3,
LB.1,
and,
importantly,
KP.3.1.1,
which
now
expanding
most
rapidly.
A
panel
VSV-based
pseudoviruses
representing
major
sublineages
was
generated
to
assess
their
susceptibility
neutralization
vitro.
Structural
analyses
were
then
conducted
understand
impact
specific
spike
mutations
on
virus-neutralization
results.
Pemivibart
neutralized
both
KP.2
with
comparable
activity,
whereas
its
potency
decreased
slightly
KP.3
but
substantially
KP.3.1.1.
Critically,
50%
inhibitory
concentration
KP.3.1.1
∼6
µg/mL,
or
∼32.7
fold
higher
than
that
our
study.
suggest
Q493E
S31-deletion
viral
contribute
antibody
evasion,
latter
having
a
more
pronounced
effect.
Our
findings
show
lost
substantial
rapidly
lineage
today.
Close
monitoring
clinical
efficacy
warranted.
These
results
also
highlight
imperative
expand
arsenal
preventive
agents
protect
millions
individuals
who
could
not
respond
robustly
vaccines.
Язык: Английский
Atomistic Prediction of Structures, Conformational Ensembles and Binding Energetics for the SARS-CoV-2 Spike JN.1, KP.2 and KP.3 Variants Using AlphaFold2 and Molecular Dynamics Simulations: Mutational Profiling and Binding Free Energy Analysis Reveal Epistatic Hotspots of the ACE2 Affinity and Immune Escape
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 10, 2024
Abstract
The
most
recent
wave
of
SARS-CoV-2
Omicron
variants
descending
from
BA.2
and
BA.2.86
exhibited
improved
viral
growth
fitness
due
to
convergent
evolution
functional
hotspots.
These
hotspots
operate
in
tandem
optimize
both
receptor
binding
for
effective
infection
immune
evasion
efficiency,
thereby
maintaining
overall
fitness.
lack
molecular
details
on
structure,
dynamics
energetics
the
latest
FLiRT
FLuQE
with
ACE2
antibodies
provides
a
considerable
challenge
that
is
explored
this
study.
We
combined
AlphaFold2-based
atomistic
predictions
structures
conformational
ensembles
Spike
complexes
host
dominant
JN.1,
KP.1,
KP.2
KP.3
examine
mechanisms
underlying
role
balancing
antibody
evasion.
Using
ensemble-based
mutational
scanning
spike
protein
residues
computations
affinities,
we
identified
energy
characterized
basis
epistatic
couplings
between
results
suggested
existence
interactions
sites
at
L455,
F456,
Q493
positions
enable
protect
restore
affinity
while
conferring
beneficial
escape.
To
escape
mechanisms,
performed
structure-based
profiling
several
classes
displayed
impaired
neutralization
against
BA.2.86,
KP.3.
confirmed
experimental
data
harboring
L455S
F456L
mutations
can
significantly
impair
neutralizing
activity
class-1
monoclonal
antibodies,
effects
mediated
by
facilitate
subsequent
convergence
Q493E
changes
rescue
binding.
Structural
energetic
analysis
provided
rationale
showing
BD55-5840
BD55-5514
bind
different
epitopes
retain
efficacy
all
examined
support
notion
may
favor
emergence
lineages
combinations
involving
mediators
control
balance
high
Язык: Английский
Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies
Biomolecules,
Год журнала:
2025,
Номер
15(2), С. 249 - 249
Опубликована: Фев. 8, 2025
A
growing
body
of
experimental
and
computational
studies
suggests
that
the
cross-neutralization
antibody
activity
against
Omicron
variants
may
be
driven
by
balance
tradeoff
between
multiple
energetic
factors
interaction
contributions
evolving
escape
hotspots
involved
in
antigenic
drift
convergent
evolution.
However,
dynamic
details
quantifying
contribution
these
factors,
particularly
balancing
nature
specific
interactions
formed
antibodies
with
epitope
residues,
remain
largely
uncharacterized.
In
this
study,
we
performed
molecular
dynamics
simulations,
an
ensemble-based
deep
mutational
scanning
SARS-CoV-2
spike
binding
free
energy
computations
for
two
distinct
groups
broadly
neutralizing
antibodies:
E1
group
(BD55-3152,
BD55-3546,
BD5-5840)
F3
(BD55-3372,
BD55-4637,
BD55-5514).
Using
approaches,
examined
determinants
which
potent
can
evade
immune
resistance.
Our
analysis
revealed
emergence
a
small
number
positions
correspond
to
R346
K444
strong
van
der
Waals
act
synchronously,
leading
large
contribution.
According
our
results,
Abs
effectively
exploit
hotspot
clusters
hydrophobic
sites
are
critical
functions
along
selective
complementary
targeting
positively
charged
important
ACE2
binding.
Together
conserved
epitopes,
lead
expand
breadth
resilience
neutralization
shifts
associated
viral
The
results
study
demonstrate
excellent
qualitative
agreement
predicted
mutations
respect
latest
experiments
on
average
scores.
We
argue
epitopes
leverage
stability
binding,
while
tend
emerge
synergistically
electrostatic
interactions.
Язык: Английский
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
Cell Reports,
Год журнала:
2025,
Номер
44(4), С. 115543 - 115543
Опубликована: Апрель 1, 2025
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
continues
to
evolve
and
spread,
it
remains
critical
understand
the
functional
consequences
of
mutations
in
dominant
viral
variants.
The
recombinant
JN.1
subvariant
XEC
recently
replaced
KP.3.1.1
become
most
prevalent
worldwide.
Here,
we
measure
vitro
neutralization
by
human
sera,
monoclonal
antibodies,
soluble
ACE2
(hACE2)
receptor
relative
parental
subvariants
KP.3
JN.1.
are
slightly
more
resistant
(1.3-
1.6-fold)
than
serum
antigenically
similar.
Both
also
demonstrate
greater
resistance
select
antibodies
hACE2,
all
which
target
top
spike.
Our
findings
suggest
that
upward
motion
receptor-binding
domain
spike
may
be
partially
hindered
N-terminal
XEC,
allowing
these
better
evade
up
position
have
a
growth
advantage.
Язык: Английский
Exploring Diverse Binding Mechanisms of Broadly Neutralizing Antibodies S309, S304, CYFN-1006 and VIR-7229 Targeting SARS-CoV-2 Spike Omicron Variants: Integrative Computational Modeling Reveals Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape
Опубликована: Апрель 17, 2025
Abstract
Evolution
of
SARS-CoV-2
has
led
to
the
emergence
variants
with
increased
immune
evasion
capabilities,
posing
significant
challenges
antibody-based
therapeutics
and
vaccines.
The
cross-neutralization
activity
antibodies
against
Omicron
is
governed
by
a
complex
delicate
interplay
multiple
energetic
factors
interaction
contributions.
In
this
study,
we
conducted
comprehensive
analysis
interactions
between
receptor-binding
domain
(RBD)
spike
protein
four
neutralizing
S309,
S304,
CYFN1006,
VIR-7229.
Using
integrative
computational
modeling
that
combined
all-atom
molecular
dynamics
(MD)
simulations,
mutational
scanning,
MM-GBSA
binding
free
energy
calculations,
elucidated
structural,
energetic,
dynamic
determinants
antibody
binding.
Our
findings
reveal
distinct
mechanisms
evolutionary
adaptation
driving
broad
neutralization
effect
these
antibodies.
We
show
S309
targets
conserved
residues
near
ACE2
interface,
leveraging
synergistic
van
der
Waals
electrostatic
interactions,
while
S304
focuses
on
fewer
but
sensitive
residues,
making
it
more
susceptible
escape
mutations.
CYFN-1006.1
CYFN-1006.2
highlights
epitope
coverage
critical
anchors
at
T345,
K440,
T346,
enhancing
its
efficacy
carrying
K356T
mutation
which
caused
from
broadly
potent
VIR-7229
XBB.1.5
EG.5
emphasized
large
structurally
epitope,
demonstrating
certain
adaptability
compensatory
effects
F456L
L455S
Mutational
profiling
identified
key
crucial
for
binding,
including
P337,
R346
T385
K386
underscoring
their
roles
as
"weak
spots"
balance
viral
fitness
evasion.
results
demonstrate
good
agreement
predicted
hotspots
mutations
respect
latest
experiments
average
scores.
study
dissect
importance
targeting
diverse
epitopes
counteract
resistance.
Broad-spectrum
CYFN1006
maintain
across
achieve
convergent
evolution
enabling
tolerance
in
positions
through
structural
interface.
underscore
diversity
employed
different
basis
high
affinity
excellent
generation
Язык: Английский
Tracking KP.2 SARS-CoV-2 Variant in India and the Clinical Profile of KP.2 Cases in Maharashtra, India
Cureus,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 3, 2024
Background:
Following
the
emergence
of
JN.1
SARS-CoV-2
variant,
variants
with
key
mutations
in
spike
protein,
such
as
L455F,
F456L,
and
R346T,
were
identified.
In
early
January
2024,
KP.2
(JN.1.11.1.2)
variant
was
first
identified
clinical
samples.
Its
increasing
global
prevalence
has
raised
concerns
over
its
transmission
impact.
The
study
investigates
KP.2*'s
(*indicates
all
sub-lineages)
spread
severity
Maharashtra.
Methods:
This
involved
5,173
Indian
whole
genome
sequences
collection
dates
between
November
1,
2023
June
24,
2024.
Lineage
analysis
performed
using
Nextclade
software
(version
3.8.0).
Telephonic
interviews
conducted
to
confirm
demographic
details
obtain
information
on
KP.2*
cases.
obtained
data
recorded
analyzed
Microsoft®
Excel
(Microsoft
Corporation,
Redmond,
WA).
Results:
Among
analyzed,
JN.1*
appeared
predominant
lineage
(65.96%,
3412/5173),
followed
by
(7.83%,
405/5173)
KP.1*
(3.27%,
169/5173).
India,
detected
December
2,
2023,
Odisha.
majority
from
Maharashtra
(248/405,
61.23%),
West
Bengal
(38/405,
9.38%),
Gujarat
(27/405,
6.67%),
Rajasthan
(24/405,
5.93%).
reported
included
160
cases
Of
these,
95.63%
(153/160)
presented
mild
symptoms,
fever
(108/160,
67.50%),
cold
(87/160,
54.38%),
cough
(80/160,
50%),
sore
throat
(44/160,
27.5%),
body
ache
(43/160,
26.88%),
fatigue
(42/160,
26.25%).
About
33.13%
(53/160)
required
institutional
quarantine
or
hospitalization,
rest
managed
at
home.
those
hospitalized,
50.94%
(27/53)
received
conservative
treatment,
while
49.06%
(26/53)
needed
supplemental
oxygen,
steroids,
antiviral
therapy.
Regarding
vaccination
status,
89.38%
(143/160)
had
least
one
dose
COVID-19
vaccine,
whereas
10%
(16/160)
unvaccinated,
unvaccinated
being
children
aged
zero
nine
years
(7/16,
43.75%).
overall
recovery
rate
for
99.38%
(159/160),
only
0.62%
(1/160)
succumbing
disease.
Conclusion:
become
dominant
India
Despite
affected
individuals
experiencing
studies
have
shown
lower
neutralization
titers
high
infectivity
due
FLiRT
mutations,
suggesting
KP.2's
potential
rise
dominance.
Язык: Английский
Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 20, 2024
Abstract
The
growing
body
of
experimental
and
computational
studies
suggested
that
the
cross-neutralization
antibody
activity
against
Omicron
variants
may
be
driven
by
balance
tradeoff
multiple
energetic
factors
interaction
contributions
evolving
escape
hotspots
involved
in
antigenic
drift
convergent
evolution.
However,
dynamic
details
quantifying
contribution
these
factors,
particularly
balancing
nature
specific
interactions
formed
antibodies
with
epitope
residues
remain
scarcely
characterized.
In
this
study,
we
performed
molecular
dynamics
simulations,
ensemble-based
deep
mutational
scanning
SARS-CoV-2
spike
binding
free
energy
computations
for
two
distinct
groups
broadly
neutralizing
:
E1
group
(BD55-3152,
BD55-3546
BD5-5840)
F3
(BD55-3372,
BD55-4637
BD55-5514).
Using
approaches,
examine
determinants
which
potent
can
largely
evade
immune
resistance.
Our
analysis
revealed
emergence
a
small
number
positions
correspond
to
R346
K444
strong
van
der
Waals
act
synchronously
leading
large
contribution.
According
our
results,
Abs
effectively
exploit
hotspot
clusters
hydrophobic
sites
critical
functions
along
selective
complementary
targeting
positively
charged
are
important
ACE2
binding.
Together
conserved
epitopes,
lead
expanded
neutralization
breadth
resilience
shift
associated
viral
results
study
demonstrate
excellent
qualitative
agreement
between
predicted
mutations
respect
latest
experiments
on
average
scores.
We
argue
epitopes
leverage
stability
binding,
while
tend
emerge
synergistically
electrostatic
interactions.
Язык: Английский